CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Context: Patients with B cell non-Hodgkin lymphoma and chronic lymphocytic leukemia (NHL/CLL) are at increased risk of morbidity and mortality from SARS-CoV-2 infection. Anti-SARS-CoV-2 vaccination is highly recommended for these patients but their antibody responses after the initial vaccination se...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Andres, Lai, Lilin, Akhtar, Akil, Linderman, Susanne, Orellana-Noia, Victor, Saini, Manpreet, Valanparambil, Rajesh, Blum, Kristie, Allen, Pamela, Lechowicz, Mary, Romancik, Jason, Ayers, Amy, O'Leary, Colin, Churnetski, Michael, Kives, Melissa, Nooka, Ajay, Koff, Jean, Dhodapkar, Madhav, Suthar, Mehul, Cohen, Jonathon, Ahmed, Rafi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acute Lymphoblastic Leukemia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489239/
http://dx.doi.org/10.1016/S2152-2650(22)01352-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489239/
http://dx.doi.org/10.1016/S2152-2650(22)01352-0

Ejemplares similares